FDA Announces Final Rule on LDT Regulation
The U.S. FDA finalized a rule regarding its oversight of LDTs to make explicit that IVDs are considered devices under the FD&C Act.
Read MorePosted by Andy Lundin | Apr 29, 2024 | Compliance |
The U.S. FDA finalized a rule regarding its oversight of LDTs to make explicit that IVDs are considered devices under the FD&C Act.
Read MorePosted by Andy Lundin | Apr 29, 2024 | Disease States |
The FDA approved Labcorp’s companion diagnostic test designed to determine eligibility for Pfizer’s gene therapy for hemophilia B patients.
Read MorePosted by Andy Lundin | Apr 29, 2024 | Molecular Diagnostics |
GenomOncology announced enhancements to its Pathology Workbench software, which features improved support for germline and somatic testing.
Read MorePosted by Andy Lundin | Apr 26, 2024 | Gastrointestinal Infections, Lab Automation, Microbiology Instruments, Sepsis |
Bruker enhanced diagnostic solutions in microbial identification, antimicrobial susceptibility testing, early sepsis diagnostics, and more.
Read MorePosted by Andy Lundin | Apr 24, 2024 | Lab Management |
ELLKAY’s lab enterprise solution facilitates electronic orders, simplifies results delivery, and streamlines reimbursement processes.
Read More